Literature DB >> 10829088

Role of sympathetic nervous system and neuropeptides in obesity hypertension.

J E Hall1, M W Brands, D A Hildebrandt, J Kuo, S Fitzgerald.   

Abstract

Obesity is the most common cause of human essential hypertension in most industrialized countries. Although the precise mechanisms of obesity hypertension are not fully understood, considerable evidence suggests that excess renal sodium reabsorption and a hypertensive shift of pressure natriuresis play a major role. Sympathetic activation appears to mediate at least part of the obesity-induced sodium retention and hypertension since adrenergic blockade or renal denervation markedly attenuates these changes. Recent observations suggest that leptin and its multiple interactions with neuropeptides in the hypothalamus may link excess weight gain with increased sympathetic activity. Leptin is produced mainly in adipocytes and is believed to regulate energy balance by acting on the hypothalamus to reduce food intake and to increase energy expenditure via sympathetic activation. Short-term administration of leptin into the cerebral ventricles increases renal sympathetic activity, and long-term leptin infusion at rates that mimic plasma concentrations found in obesity raises arterial pressure and heart rate via adrenergic activation in non-obese rodents. Transgenic mice overexpressing leptin also develop hypertension. Acute studies suggest that the renal sympathetic effects of leptin may depend on interactions with other neurochemical pathways in the hypothalamus, including the melanocortin-4 receptor (MC4-R). However, the role of this pathway in mediating the long-term effects of leptin on blood pressure is unclear. Also, it is uncertain whether there is resistance to the chronic renal sympathetic and blood pressure effects of leptin in obese subjects. In addition, leptin also has other cardiovascular and renal actions, such as stimulation of nitric oxide formation and improvement of insulin sensitivity, which may tend to reduce blood pressure in some conditions. Although the role of these mechanisms in human obesity has not been elucidated, this remains a fruitful area for further investigation, especially in view of the current "epidemic" of obesity in most industrialized countries.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10829088     DOI: 10.1590/s0100-879x2000000600001

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  20 in total

Review 1.  The role of the nervous system in hypertension.

Authors:  J M Wyss; S H Carlson
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 2.  Neural innervation of white adipose tissue and the control of lipolysis.

Authors:  Timothy J Bartness; Yang Liu; Yogendra B Shrestha; Vitaly Ryu
Journal:  Front Neuroendocrinol       Date:  2014-04-13       Impact factor: 8.606

Review 3.  Cardiovascular and sympathetic effects of leptin.

Authors:  Kamal Rahmouni; William G Haynes; Allyn L Mark
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

4.  Mechanisms mediating renal sympathetic activation to leptin in obesity.

Authors:  Donald A Morgan; Daniel R Thedens; Robert Weiss; Kamal Rahmouni
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-09-24       Impact factor: 3.619

Review 5.  The role of the sympathetic nervous system in obesity-related hypertension.

Authors:  Alexandre A da Silva; Jussara do Carmo; John Dubinion; John E Hall
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

Review 6.  Insulin resistance and the sympathetic nervous system.

Authors:  Brent M Egan
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

Review 7.  PI3K signaling: A key pathway in the control of sympathetic traffic and arterial pressure by leptin.

Authors:  Shannon M Harlan; Kamal Rahmouni
Journal:  Mol Metab       Date:  2013-03-23       Impact factor: 7.422

8.  Protein phosphatase 1b in the solitary tract nucleus is necessary for normal baroreflex function.

Authors:  Amy C Arnold; Manisha Nautiyal; Debra I Diz
Journal:  J Cardiovasc Pharmacol       Date:  2012-05       Impact factor: 3.105

Review 9.  The pathophysiology of hypertension in systemic lupus erythematosus.

Authors:  Michael J Ryan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-01-21       Impact factor: 3.619

10.  Anticontractile Effect of Perivascular Adipose Tissue and Leptin are Reduced in Hypertension.

Authors:  Beatriz Gálvez-Prieto; Beatriz Somoza; Marta Gil-Ortega; Concha F García-Prieto; Ana I de Las Heras; M Carmen González; Silvia Arribas; Isabel Aranguez; Juliane Bolbrinker; Reinhold Kreutz; Mariano Ruiz-Gayo; Maria S Fernández-Alfonso
Journal:  Front Pharmacol       Date:  2012-06-05       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.